Hrt Financial LP Accolade, Inc. Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$10.52 - $16.06 $532,795 - $813,374	50,646 Added 321.38%	66,405 $894,000
Q1 2023 May 12, 2023	SELL	$7.32 - $14.38 $53,648 - $105,391	-7,329 Reduced 31.74%	15,759 $226,000
Q4 2022 Feb 10, 2023	BUY	$7.19 - $13.16 $166,002 - $303,838	23,088 New	23,088 $179,000
Q2 2022 Aug 12, 2022	BUY	$5.28 - $18.9 $398,529 - $1.43 Million	75,479 New	75,479 $558,000
Q1 2022 May 16, 2022	SELL	$12.92 - $27.18 $687,964 - $1.45 Million	-53,248 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$21.96 - $42.69 $1.17 Million - $2.27 Million	53,248 New	53,248 $1.4 Million
Q1 2021 May 17, 2021	SELL	$38.1 - $59.09 $675,551 - $1.05 Million	-17,731 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$33.26 - $59.72 $589,733 - $1.06 Million	17,731 New	17,731 $771,000

171

67.6M

181K

1.66M

Ticker ACCD
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 71,938,896
Market Cap $250M
Description
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.